Tri Locum Partners LP Teva Pharmaceutical Industries LTD Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

A detailed history of Tri Locum Partners LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tri Locum Partners LP holds 2,755,737 shares of TEVA stock, worth $59.2 Million. This represents 13.26% of its overall portfolio holdings.

Number of Shares
2,755,737
Previous 2,550,307 8.06%
Holding current value
$59.2 Million
Previous $41.4 Million 19.83%
% of portfolio
13.26%
Previous 10.7%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$15.81 - $18.96 $3.25 Million - $3.89 Million
205,430 Added 8.06%
2,755,737 $49.7 Million
Q2 2024

Aug 14, 2024
BUY
$12.78 - $17.4 $4.27 Million - $5.81 Million
334,119 Added 15.08%
2,550,307 $41.4 Million
Q1 2024

May 15, 2024
BUY
$10.67 - $14.43 $4.5 Million - $6.09 Million
421,853 Added 23.51%
2,216,188 $31.3 Million
Q4 2023

Feb 14, 2024
SELL
$8.12 - $10.63 $6.81 Million - $8.91 Million
-838,558 Reduced 31.85%
1,794,335 $18.7 Million
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $11.4 Million - $16.3 Million
1,527,123 Added 138.1%
2,632,893 $26.9 Million
Q2 2023

Aug 14, 2023
BUY
$7.2 - $9.47 $672,458 - $884,469
93,397 Added 9.23%
1,105,770 $8.33 Million
Q1 2023

May 15, 2023
BUY
$8.36 - $11.37 $8.46 Million - $11.5 Million
1,012,373 New
1,012,373 $8.96 Million
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $4.69 Million - $8.17 Million
683,613 New
683,613 $5.52 Million

Others Institutions Holding TEVA

# of Institutions
627
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email